• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Substantial prevalence of transthyretin amyloid cardiomyopathy present in patients with heart failure with preserved ejection fraction

byYuchen DaiandMichael Pratte
September 2, 2021
in Cardiology, Chronic Disease
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Transthyretin amyloid cardiomyopathy was present in a substantial number of patients with heart failure with preserved ejection fraction and ventricular wall thickening in a community-based cohort, especially among older men.

2. With effective therapy available to treat transthyretin amyloid cardiomyopathy, targeted systematic evaluation in patients with heart failure with preserved ejection fraction may aid in its early diagnosis and offer therapeutically relevant phenotyping of the clinical syndrome.

Evidence Rating Level: 2 (Good)

Study Rundown: Approximately half of patients with heart failure (HF) have preserved ejection fraction (HFpEF). Increased left ventricular wall thickness is commonly observed in these patients. Although ventricular wall thickening in HFpEF is more commonly associated with hypertension-induced or volume-overload myocardial hypertrophy, a smaller group of patients have been found to have cardiac amyloid fibril infiltration, also known as transthyretin amyloid cardiomyopathy (ATTR-CM), which can mimic HFpEF clinically. However, where HFpEF caused by most other etiologies has no effective curative treatment, HFpEF due to ATTR-CM has highly effective therapy and is believed to be underrecognized in patients with heart failure. This cohort study sought to determine the prevalence of ATTR-CM among consecutive patients with HFpEF clinical syndrome and left ventricular wall thickening in southeastern Minnesota. The main endpoint of the analysis was ATTR-CM prevalence overall and stratified by strategy (clinical diagnosis or systematic screening), age, and sex. Prevalence was defined with or without screening using technetium Tc 99m pyrophosphate scintigraphy and appropriate reflex testing to exclude light chain amyloidosis. Among 1,235 consecutive patients with HFpEF, only 16 patients (1.3%; all men) had clinically recognized ATTR-CM. Subsequently, in 286 patients where systematic screening was performed using pyrophosphate scanning and reflex testing, 18 of 286 patients (6.3%; 10.0% of men and 2.2% of women) had ATTR-CM. These findings suggested that within a community-based cohort, ATTR-CM was present in a substantial number of patients with HFpEF and ventricular wall thickening, especially among older men. With effective therapy available to treat ATTR-CM, systematic evaluation in such patients may significantly aid in its early diagnosis and offer therapeutically relevant phenotyping of HFpEF. A limitation of this study was the predominance of mainly White participants, which does not accurately reflect the demographic characteristics of the US population overall, especially in more ethnically diverse urban centers. Thus, this may have underestimated the prevalence of ATTR-CM in the general US population and decreased the generalizability of the study findings.

Click to read the study in JAMA Cardiology

Relevant Reading: Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction

In-Depth [prospective cohort]: This population-based cohort study assessed 1,235 prospectively identified consecutive patients (median age, 80 years; IQR, 72-87 years; 630 [51%] male) with HFpEF from southeastern Minnesota, including 286 patients in a community systematic screening subcohort (median age, 78 years; IQR, 71-84 years; 150 [52%] male). Inclusion criteria included patients with a HF diagnosis, age of 60 years or older, ejection fraction of 40% or greater, and ventricular wall thickness of 12 mm or greater. In total, 286 subjects underwent technetium Tc 99m pyrophosphate scanning between October 2017 and March 2020, where 884 individuals did not have ATTR-CM, contraindications to technetium Tc 99mpyrophosphate scintigraphy, or other barriers to study participation. Within the non-screening community cohort, 16 of 1,235 patients (1.3%; 95%CI, 0.7%-2.1%) had ATTR-CM, where the prevalence was 2.5% (95%CI, 1.4%-4.0%) in men and 0% (95%CI, 0.0%-0.6%) in women. Within the community screening cohort, 18 of 286 patients (6.3%; 95%CI, 3.8%-9.8%) had ATTR-CM, where the prevalence was 10.0% (15 of 150 men; 95%CI, 5.7%-16.1%) in men and 2.2% (3 of 136 women; 95%CI, 0.4%-6.3%) in women. Furthermore, prevalence increased with age from 0% in patients 60 to 69 years to 21% in patients 90 years and older (P < .001).

RELATED REPORTS

Sodium-glucose cotransporter-2 inhibitors are of intermediate or low economic value in the treatment of heart failure with preserved ejection fraction

Days alive out of hospital after ventricular assist device implantation vary with comorbidity status

NT-proBNP associated with risk for incident heart failure and all-cause mortality

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: heart failurehfpefHFpEF (heart failure with preserved ejection fraction
Previous Post

#VisualAbstract: Reduced intensity chemotherapy improves quality of life without reducing survival in frail or elderly patients with gastroesophageal cancer

Next Post

More omega-3 and less omega-6 fatty acid consumption associated with reduced migraine frequency and severity

RelatedReports

Cardiology

Sodium-glucose cotransporter-2 inhibitors are of intermediate or low economic value in the treatment of heart failure with preserved ejection fraction

March 16, 2023
Mesenchymal precursor cell transplant did not improve weaning from device support in LVAD patients
Cardiology

Days alive out of hospital after ventricular assist device implantation vary with comorbidity status

February 24, 2023
Quick Take: Association of African Ancestry with Electrocardiographic Voltage and Concentric Left Ventricular Hypertrophy: The Dallas Heart Study
Cardiology

NT-proBNP associated with risk for incident heart failure and all-cause mortality

February 19, 2023
StudyGraphics

#VisualAbstract: Moderately accelerated cardiac pacing may be beneficial in patients with heart failure with preserved ejection fraction

February 15, 2023
Next Post
Galcanezumab reduces the frequency of episodic cluster headaches

More omega-3 and less omega-6 fatty acid consumption associated with reduced migraine frequency and severity

#VisualAbstract Obinutuzumab-atezolizumab-lenalidomide is effective and tolerable in patients with relapsed/refractory follicular lymphoma

#VisualAbstract Obinutuzumab-atezolizumab-lenalidomide is effective and tolerable in patients with relapsed/refractory follicular lymphoma

Quick Take: Amyotrophic Lateral Sclerosis versus Multifocal Motor Neuropathy: Utility of MR Neurography

Variants in the SPTLC1 gene associated with juvenile amyotrophic lateral sclerosis

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Similar perinatal outcomes observed amongst conception via natural and assisted reproductive means
  • Combination doxycycline and azithromycin therapy effective in treating severe scrub typhus
  • Adenoma detection rate is inversely associated with post-colonoscopy colorectal cancer risk
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options